All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
AAHP Submits Comments and Briefs Industry on New FDA Requirements
In November 2021, FDA announced a guidance regarding annual reporting of quantities of drugs manufactured or compounded. The deadline for the first reports, covering quantities...
Supporting Your Success in 2021 and 2022
By Mark Land, AAHP President As challenges continue into 2022, so will opportunities. COVID-19 heightened the awareness and value of many OTC and self-care products,...
What Was Important to AAHP Members in 2021?
2021 was a year of successes and celebrations, but AAHP members found some topics especially important. From people in homeopathy to important regulatory matters, here...
Homeopathic Human Growth Hormone and the Illegal Risks
by Eric L. Foxman, AAHP Secretary, Pharm. (Ret.) A quick scan of the internet shows that consumers can readily purchase over-the-counter products that allegedly...
Quality Agreement Development and Importance
Supply Chain Management for Homeopathy, Part 3 of 4 By Tim Clarot, Industry Consultant This third article in the supply chain management series will...
Members Heads-Up on Two New Hot FDA Announcements
By Mark Land, AAHP President Recently members received a special e-blast alerting them of two important FDA announcements. While members can read more on a...